A Nuclear Magnetic Resonance Spectroscopy Method in Characterization of Blood Metabolomics for Alzheimer’s Disease
There is currently a crucial need for improved diagnostic techniques and targeted treatment methods for Alzheimer’s disease (AD), a disease which impacts millions of elderly individuals each year. Metabolomic analysis has been proposed as a potential methodology to better investigate and understand...
Main Authors: | JianXiang Weng, Isabella H. Muti, Anya B. Zhong, Pia Kivisäkk, Bradley T. Hyman, Steven E. Arnold, Leo L. Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/12/2/181 |
Similar Items
-
Preanalytical Pitfalls in Untargeted Plasma Nuclear Magnetic Resonance Metabolomics of Endocrine Hypertension
by: Nikolaos G. Bliziotis, et al.
Published: (2022-07-01) -
Investigating the Therapeutic Mechanisms of Total Saikosaponins in Alzheimer’s Disease: A Metabolomic and Proteomic Approach
by: Huiling Wei, et al.
Published: (2025-01-01) -
Anti-Alzheimer potential of Solanum lycopersicum seeds: in vitro, in vivo, metabolomic, and computational investigations
by: Hussain T. Bakhsh, et al.
Published: (2024-01-01) -
Studying Alzheimer’s disease through an integrative serum metabolomic and lipoproteomic approach
by: Alessia Vignoli, et al.
Published: (2025-01-01) -
Saliva Proteome, Metabolome and Microbiome Signatures for Detection of Alzheimer’s Disease
by: Maxime François, et al.
Published: (2024-12-01)